View in EDS HTML Full Text PDF Full Text

Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes.

Saved in:
Bibliographic Details
Title: Weight-independent amelioration of adipokine profile by enavogliflozin, a selective SGLT2 inhibitor, in patients with type 2 diabetes.
Authors: Lyu, Young Sang1 (AUTHOR) lyu0923@chosun.ac.kr, Lee, Hansol2 (AUTHOR) hslee110@daewoong.co.kr, Kim, Kyung-Soo3 (AUTHOR) kks982@hanmail.net, Hong, Sangmo4 (AUTHOR) lanugo35@gmail.com, Park, Cheol-Young5 (AUTHOR) cydoctor@skku.edu
Source: Cardiovascular Diabetology. 8/31/2025, Vol. 24 Issue 1, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14752840
DOI:10.1186/s12933-025-02917-z